• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Concentra Group Holdings Parent Inc.

    3/18/25 8:01:59 AM ET
    $CON
    Medical Specialities
    Health Care
    Get the next $CON alert in real time by email
    DEFA14A 1 tm258915d3_defa14a.htm DEFA14A

     

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
     

     

    SCHEDULE 14A 

     

    INFORMATION REQUIRED IN PROXY STATEMENT
    SCHEDULE 14A INFORMATION
     

     

    Proxy Statement Pursuant to Section 14(a) of 

    the Securities Exchange Act of 1934 (Amendment No.              )

      

    Filed by the Registrant ¨

     

    Filed by a Party other than the Registrant ¨

     

    Check the appropriate box:

     

    ¨Preliminary Proxy Statement

     

    ¨Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

     

    ¨Definitive Proxy Statement

     

    xDefinitive Additional Materials

     

    ¨Soliciting Material under §240.14a-12

     

    Concentra Group Holdings Parent, Inc. 

     

    (Name of Registrant as Specified In Its Charter)

     

     

     

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

     

    Payment of Filing Fee (Check the appropriate box):

     

    xNo fee required.

     

    ¨Fee paid previously with preliminary materials.

     

    ¨Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a

     

     

     

     

     

     

    GRAPHIC

    Step 1: Go to www.envisionreports.com/CON. Step 2: Click on Cast Your Vote or Request Materials. Step 3: Follow the instructions on the screen to log in. www.envisionreports.com/CON Online Go to www.envisionreports.com/CON or scan the QR code — login details are located in the shaded bar below. Stockholder Meeting Notice 043CFE Important Notice Regarding the Availability of Proxy Materials for the Concentra Group Holdings Parent, Inc. Meeting to be Held on Thursday, May 1, 2025 Under Securities and Exchange Commission rules, you are receiving this notice that the proxy materials for the annual stockholders’ meeting are available on the Internet. Follow the instructions below to view the materials and vote online or request a copy. The items to be voted on and location of the annual meeting are on the reverse side. Your vote is important! This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The proxy statement and annual report to stockholders are available at: Obtaining a Copy of the Proxy Materials – If you want to receive a copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. Please make your request as instructed on the reverse side on or before April 21, 2025 to facilitate timely delivery. 2NOT Easy Online Access — View your proxy materials and vote. When you go online, you can also help the environment by consenting to receive electronic delivery of future materials. Concentra Group Holdings Parent, Inc. Step 4: Make your selections as instructed on each screen for your delivery preferences. Step 5: Vote your shares.

    GRAPHIC

    Here’s how to order a copy of the proxy materials and select delivery preferences: Current and future delivery requests can be submitted using the options below. If you request an email copy, you will receive an email with a link to the current meeting materials. PLEASE NOTE: You must use the number in the shaded bar on the reverse side when requesting a copy of the proxy materials. — Internet – Go to www.envisionreports.com/CON. Click Cast Your Vote or Request Materials. — Phone – Call us free of charge at 1-866-641-4276. — Email – Send an email to [email protected] with “Proxy Materials Concentra Group Holdings Parent, Inc.” in the subject line. Include your full name and address, plus the number located in the shaded bar on the reverse side, and state that you want a paper copy of the meeting materials. To facilitate timely delivery, all requests for a paper copy of proxy materials must be received by April 21, 2025. Dear Concentra Group Holdings Parent, Inc. Stockholder: The 2025 Annual Meeting of Stockholders of Concentra Group Holdings Parent, Inc. will be held on Thursday, May 1, 2025 at 11:00am Central Time, virtually via the internet at https://meetnow.global/MG7NTCU. To access the virtual meeting, you must have the information that is printed in the shaded bar located on the reverse side of this form. Proposals to be voted on at the meeting are listed below along with the Board of Directors’ recommendations. The Board of Directors recommend a vote FOR all the nominees listed, FOR Proposal 2, 1 YEAR for Proposal 3, and FOR Proposal 4: 1. Elect two Class I directors, each for a term of three years or until their respective successors have been elected and qualified: 01 - Cheryl B. Pegus 02 - Daniel J. Thomas 2. Hold a non-binding advisory vote on the compensation of our named executive officers. 3. Hold a non-binding advisory vote on the frequency of the advisory vote on the compensation of our named executive officers. 4. Ratify the appointment of PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2025. PLEASE NOTE – YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must go online or request a paper copy of the proxy materials to receive a proxy card. Stockholder Meeting Notice

    Get the next $CON alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CON

    DatePrice TargetRatingAnalyst
    9/18/2025$31.00Overweight
    Analyst
    12/16/2024$24.00Neutral → Buy
    BofA Securities
    10/7/2024$30.50 → $24.00Buy → Neutral
    BofA Securities
    8/20/2024$33.00Outperform
    RBC Capital Mkts
    8/19/2024Buy
    BofA Securities
    8/19/2024$29.00Buy
    Deutsche Bank
    8/19/2024$29.00Overweight
    JP Morgan
    8/19/2024$32.00Buy
    Goldman
    More analyst ratings

    $CON
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Concentra with a new price target

    Analyst resumed coverage of Concentra with a rating of Overweight and set a new price target of $31.00

    9/18/25 8:38:55 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent upgraded by BofA Securities with a new price target

    BofA Securities upgraded Concentra Group Holdings Parent from Neutral to Buy and set a new price target of $24.00

    12/16/24 6:50:31 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent downgraded by BofA Securities with a new price target

    BofA Securities downgraded Concentra Group Holdings Parent from Buy to Neutral and set a new price target of $24.00 from $30.50 previously

    10/7/24 7:46:54 AM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Newton William Keith gifted 89,081 shares and received a gift of 89,081 shares, decreasing direct ownership by 18% to 393,750 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    12/18/25 4:25:42 PM ET
    $CON
    Medical Specialities
    Health Care

    Officer Ryan Timothy F. covered exercise/tax liability with 5,903 shares, decreasing direct ownership by 5% to 114,097 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    12/1/25 4:23:27 PM ET
    $CON
    Medical Specialities
    Health Care

    Officer Rhine Michael D. covered exercise/tax liability with 3,935 shares, decreasing direct ownership by 5% to 76,163 units (SEC Form 4)

    4 - Concentra Group Holdings Parent, Inc. (0002014596) (Issuer)

    12/1/25 4:22:41 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Concentra Announces Preliminary 2025 Financial Results, Provides 2026 Financial Guidance, and Announces Q4 2025 Earnings Call Date

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services by number of locations, today released preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, exceeding its previously issued guidance for full year 2025. In addition, the Company is releasing its preliminary 2026 business outlook, and publishing a detailed Investor Book providing a comprehensive primer on Concentra's business and industry. Concentra will issue its full fourth quarter and fiscal year 2025 financial results on February 26, 2026 and will host a conference call on Februa

    1/28/26 4:24:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Expands to Tucker, Georgia

    Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Tucker, Georgia. The medical center, Concentra Tucker, is conveniently located at 4434 Hugh Howell Road, Tucker, Georgia 30084. "Georgia is a strong market for Concentra," said Janet Cobb, MD, senior vice president of Concentra medical operations. "Expanding to Tucker gives us another access point in DeKalb County and will enable us to reach more Georgia employers and provide quality occupational health services to their workers." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-rel

    1/26/26 8:00:00 AM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Adds New Medical Center in Hialeah, Florida

    Concentra® (NYSE:CON), the nation's leader in occupational medicine, today announced the opening of a new medical center in Hialeah, Florida. The medical center, Concentra Hialeah, is conveniently located at 855 East 8th Avenue, Hialeah, Florida 33010. "Hialeah has shown great potential for Concentra," said Janet Cobb, MD, senior vice president of Concentra medical operations. "By optimizing our presence in Hialeah, we intend to serve more employers and provide greater access to care." Concentra will provide work injury care, physical therapy, drug testing, DOT physical exams, pre-placement exams, and other employer-related health services from its new location in Hialeah. Telemedicine fo

    12/15/25 9:30:00 AM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    SEC Filings

    View All

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    1/28/26 4:54:49 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Concentra Group Holdings Parent, Inc. (0002014596) (Filer)

    1/12/26 9:01:52 AM ET
    $CON
    Medical Specialities
    Health Care

    Amendment: SEC Form SCHEDULE 13D/A filed by Concentra Group Holdings Parent Inc.

    SCHEDULE 13D/A - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    11/26/25 4:15:20 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Financials

    Live finance-specific insights

    View All

    Concentra Announces Preliminary 2025 Financial Results, Provides 2026 Financial Guidance, and Announces Q4 2025 Earnings Call Date

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services by number of locations, today released preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, exceeding its previously issued guidance for full year 2025. In addition, the Company is releasing its preliminary 2026 business outlook, and publishing a detailed Investor Book providing a comprehensive primer on Concentra's business and industry. Concentra will issue its full fourth quarter and fiscal year 2025 financial results on February 26, 2026 and will host a conference call on Februa

    1/28/26 4:24:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra® to Announce Third Quarter 2025 Results on Thursday, November 6, 2025

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON) will release the financial results for its third quarter ended September 30, 2025, on Thursday, November 6, 2025, after the market closes. Concentra will host a conference call regarding its financial results on Friday, November 7, 2025, at 9 a.m. Eastern Time. The conference call will be a live webcast and can be accessed via this Earnings Call Webcast Link or via Concentra's investor relations website. A replay of the webcast will be available shortly after the call at the same locations. Participants may join the audio-only version of the webcast or participate in the question-and-answer session by calling: Toll Free:

    10/6/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Group Holdings Parent, Inc. Announces Results For Its Second Quarter Ended June 30, 2025, Cash Dividend, and Raised FY 2025 Guidance

    Concentra Group Holdings Parent, Inc. ("Concentra," the "Company," "we," "us," or "our") (NYSE:CON), the nation's largest provider of occupational health services, today announced results for its second quarter ended June 30, 2025, the declaration of a cash dividend, and raised guidance for FY 2025. "Concentra delivered strong results in the second quarter, building on our solid start to 2025," said Keith Newton, Chief Executive Officer of Concentra. "Our results reflected strength across several key measures, including growth in patient visits, rate, revenue, and Adjusted EBITDA. We are well-positioned for continued momentum driven by the disciplined execution of our strategy by our outs

    8/7/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    $CON
    Leadership Updates

    Live Leadership Updates

    View All

    Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer

    Concentra®, (NYSE:CON) the nation's largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra's data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth priorities. "Selecting Jason as our Chief Data, Analytics, and Artificial Intelligence Officer represents the natural progression of Concentra's established foundation in data, technology, and innovation," said Keith Newton, Chief Executive Officer of Concentra. "His expertise and extensive experience will enable us to continue to operationalize

    11/10/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Concentra Announces the Appointment Of Vipin Gopal and Brigid Bonner To Its Board Of Directors

    Concentra® Group Holdings Parent, Inc. ("Concentra") (NYSE:CON), today announced the appointment of Vipin Gopal and Brigid Bonner to the Concentra Board of Directors, marking a strategic milestone for the occupational health services company. "We are pleased to welcome Vipin Gopal and Brigid Bonner to the Concentra Board," said Bob Ortenzio, Concentra's board chair. "As Concentra navigates growth and the opportunity to increase shareholder value, expanding the Board with two prominent health care leaders with data, technology, and business transformation expertise will prove to be a mobilizing force for the company." Vipin Gopal, PhD, brings over 25 years of experience successfully lead

    6/26/25 4:30:00 PM ET
    $CON
    Medical Specialities
    Health Care

    Flex Set to Join S&P MidCap 400; Azenta and Concentra Group Holdings to Join S&P SmallCap 600

    NEW YORK, Nov. 19, 2024 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600: Flex Ltd (NASD: FLEX) will replace Azenta Inc. (NASD: AZTA) in the S&P MidCap 400, and Azenta will replace Envestnet Inc. (NYSE:ENV) in the S&P SmallCap 600 effective prior to the opening of trading on Monday, November 25. Bain Capital is acquiring Envestnet in a deal expected to be completed soon, pending final closing conditions. Azenta's market capitalization is no longer representative of the mid-cap market space.Concentra Group Holdings Inc. (NYSE:CON) will replace Myers Industries Inc. (NYSE:MYE) in the S&P SmallCap 600 effective prior to the openin

    11/19/24 5:56:00 PM ET
    $AZTA
    $CON
    $ENV
    Industrial Machinery/Components
    Technology
    Medical Specialities
    Health Care

    $CON
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/9/24 6:02:26 AM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13G filed by Concentra Group Holdings Parent Inc.

    SC 13G - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/6/24 4:32:57 PM ET
    $CON
    Medical Specialities
    Health Care

    SEC Form SC 13D filed by Concentra Group Holdings Parent Inc.

    SC 13D - Concentra Group Holdings Parent, Inc. (0002014596) (Subject)

    12/3/24 4:21:17 PM ET
    $CON
    Medical Specialities
    Health Care